BRIEF-Kazia Therapeutics Provides Update On Paxalisib Regulatory Pathway Following Type C Meeting With FDA

Reuters

31 Dec 2024

BRIEF-<a href="https://laohu8.com/S/KZA.AU">Kazia Therapeutics</a> Provides Update On Paxalisib Regulatory Pathway Following Type C Meeting With FDA

Dec 31 (Reuters) - Kazia Therapeutics Ltd KZIA.O:

KAZIA THERAPEUTICS PROVIDES UPDATE ON PAXALISIB REGULATORY PATHWAY FOLLOWING TYPE C MEETING WITH FDA
KAZIA THERAPEUTICS LTD - FDA SAYS OS DATA NOT APPROPRIATE FOR ACCELERATED APPROVAL
KAZIA THERAPEUTICS LTD - FDA COMMENTS OS DATA SUPPORTIVE FOR PIVOTAL REGISTRATIONAL STUDY
KAZIA THERAPEUTICS LTD - ALIGNS WITH FDA ON PHASE 3 STUDY DESIGN

Source text: ID:nPn5mLr4Da

Further company coverage: KZIA.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/2495247690"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2495247690\",edition:\"fundamental\",,,undefined,":{"share":"https://ttm.financial/m/news/2495247690?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-31 21:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2495247690","market":"us","top_or_hot":-1,"title":"BRIEF-Kazia Therapeutics Provides Update On Paxalisib Regulatory Pathway Following Type C Meeting With FDA","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-<a href=\"https://laohu8.com/S/KZA.AU\">Kazia Therapeutics</a> Provides Update On Paxalisib Regulatory Pathway Following Type C Meeting With FDA</title></head><body><p><span>Dec 31 (Reuters)</span><span> - </span>Kazia <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Ltd <span>KZIA.O</span>:</p><ul><li><p>KAZIA THERAPEUTICS PROVIDES UPDATE ON PAXALISIB REGULATORY PATHWAY FOLLOWING TYPE C MEETING WITH FDA</p></li><li><p>KAZIA THERAPEUTICS LTD - FDA SAYS OS DATA NOT APPROPRIATE FOR ACCELERATED APPROVAL</p></li><li><p>KAZIA THERAPEUTICS LTD - FDA COMMENTS OS DATA SUPPORTIVE FOR PIVOTAL REGISTRATIONAL STUDY</p></li><li><p>KAZIA THERAPEUTICS LTD - ALIGNS WITH FDA ON PHASE 3 STUDY DESIGN</p></li></ul><p>Source text: <span>ID:nPn5mLr4Da</span></p><p>Further company coverage: <span>KZIA.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta content=\"text/html; charset=utf-8\" http-equiv=\"Content-Type\"/>\n<meta content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\" name=\"viewport\"/>\n<meta content=\"telephone=no,email=no,address=no\" name=\"format-detection\"/>\n<title>BRIEF-Kazia Therapeutics Provides Update On Paxalisib Regulatory Pathway Following Type C Meeting With FDA</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Kazia Therapeutics Provides Update On Paxalisib Regulatory Pathway Following Type C Meeting With FDA\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2024-12-31 21:54</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<title>BRIEF-<a href=\"https://laohu8.com/S/KZA.AU\">Kazia Therapeutics</a> Provides Update On Paxalisib Regulatory Pathway Following Type C Meeting With FDA</title><p><span>Dec 31 (Reuters)</span><span> - </span>Kazia <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> Ltd <span>KZIA.O</span>:</p><ul><li><p>KAZIA THERAPEUTICS PROVIDES UPDATE ON PAXALISIB REGULATORY PATHWAY FOLLOWING TYPE C MEETING WITH FDA</p></li><li><p>KAZIA THERAPEUTICS LTD - FDA SAYS OS DATA NOT APPROPRIATE FOR ACCELERATED APPROVAL</p></li><li><p>KAZIA THERAPEUTICS LTD - FDA COMMENTS OS DATA SUPPORTIVE FOR PIVOTAL REGISTRATIONAL STUDY</p></li><li><p>KAZIA THERAPEUTICS LTD - ALIGNS WITH FDA ON PHASE 3 STUDY DESIGN</p></li></ul><p>Source text: <span>ID:nPn5mLr4Da</span></p><p>Further company coverage: <span>KZIA.O</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"KZIA","symbol_name":"Kazia Therapeutics Limited","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241231:nTUA59PWFV:1","article_id":"2495247690","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2495247690","pubTimestamp":1735653293,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Kazia Therapeutics Provides Update On Paxalisib Regulatory Pathway Following Type C Meeting With FDADec 31 (Reuters) - Kazia Therapeutics Ltd KZIA.O:KAZIA THERAPEUTICS PROVIDES UPDATE ON PAXALIS","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"KZIA":"Kazia Therapeutics Limited","BK4139":"生物科技"},"translate_title":"简介-Kazia Therapeutics在与FDA举行C型会议后提供了Paxalisib监管途径的最新信息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KZIA":0.9},"content_text":"BRIEF-Kazia Therapeutics Provides Update On Paxalisib Regulatory Pathway Following Type C Meeting With FDADec 31 (Reuters) - Kazia Therapeutics Ltd KZIA.O:KAZIA THERAPEUTICS PROVIDES UPDATE ON PAXALISIB REGULATORY PATHWAY FOLLOWING TYPE C MEETING WITH FDAKAZIA THERAPEUTICS LTD - FDA SAYS OS DATA NOT APPROPRIATE FOR ACCELERATED APPROVALKAZIA THERAPEUTICS LTD - FDA COMMENTS OS DATA SUPPORTIVE FOR PIVOTAL REGISTRATIONAL STUDYKAZIA THERAPEUTICS LTD - ALIGNS WITH FDA ON PHASE 3 STUDY DESIGNSource text: ID:nPn5mLr4DaFurther company coverage: KZIA.O ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"policyRegulatory","news_rank":0,"symbols":[],"gpt_button":1}}}